Affinity Asset Advisors »

Guardant Health shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Guardant Health (GH) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Guardant Health

Tip: Access up to 7 years of quarterly data

All positions including Guardant Health held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Guardant Health by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.2M 250k 20.63

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Guardant Health

Vanguard Group
BlackRock
Baillie Gifford & Co
Deep Track Capital
Eventide Asset Management
Citadel Advisors
Braidwell
Parkwood
Geode Capital Management
State Street Corporation
Millennium Management
Morgan Stanley
Hanna Zanoni
Point72 Asset Management
T. Rowe Price Associates

View all funds holding Guardant Health